Skip to main content

Advertisement

SpringerLink
Log in

A step closer to effective transplant tolerance?

  • Community Corner
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Leventhal, J. et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci. Transl. Med. 4, 124ra128 (2012).

    Article  Google Scholar 

  2. Ildstad, S.T. & Sachs, D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168–170 (1984).

    Article  CAS  Google Scholar 

  3. Fudaba, Y. et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am. J. Transplant. 6, 2121–2133 (2006).

    Article  CAS  Google Scholar 

  4. Scandling, J.D. et al. Induced immune tolerance for kidney transplantation. N. Engl. J. Med. 365, 1359–1360 (2011).

    Article  CAS  Google Scholar 

  5. Kawai, T. et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358, 353–361 (2008).

    Article  CAS  Google Scholar 

  6. Newell, K.A. et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120, 1836–1847 (2010).

    Article  CAS  Google Scholar 

  7. Sagoo, P. et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J. Clin. Invest. 120, 1848–1861 (2010).

    Article  CAS  Google Scholar 

  8. Vallera, D.A., Youle, R.J., Neville, D.M. Jr. & Kersey, J.H. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti–Thy-1.2 coupled to the toxin ricin. J. Exp. Med. 155, 949–954 (1982).

    Article  CAS  Google Scholar 

  9. Cobbold, S.P., Martin, G., Qin, S. & Waldmann, H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323, 164–166 (1986).

    Article  CAS  Google Scholar 

  10. Bemelman, F., Honey, K., Adams, E., Cobbold, S. & Waldmann, H. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J. Immunol. 160, 2645–2648 (1998).

    CAS  Google Scholar 

  11. Brunstein, C.G. et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 118, 282–288 (2011).

    Article  CAS  Google Scholar 

Download references

Ethics declarations

Competing interests

L.A.T.'s wife is an employee of Novartis, and the two of them own stock in the company. The other authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

A step closer to effective transplant tolerance?. Nat Med 18, 664–665 (2012). https://doi.org/10.1038/nm.2770

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2770

  • Springer Nature America, Inc.

Search

Navigation